Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

[1]  M. Jauffret-Roustide,et al.  Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. , 2018, Journal of hepatology.

[2]  M. Dickie,et al.  Global Health Sector Strategy on Viral Hepatitis : What does it mean for Canadians ? , 2018 .

[3]  J. Leung,et al.  Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.

[4]  R. Guy,et al.  Estimating the number of people who inject drugs in Australia , 2017, BMC Public Health.

[5]  Doris Cardona,et al.  Factors associated with syringe exchange among injection drug users in Colombia , 2017 .

[6]  R. Haddad,et al.  Intranasal heroin use – an emerging trend in Lebanon: A single institution study presenting sociodemographic profiles of intranasal versus intravenous users , 2017 .

[7]  M. Çetin,et al.  Hepatitis C infection and other drug‐related harms among inpatients who injected drugs in Turkey , 2017, Journal of viral hepatitis.

[8]  M. Brugal,et al.  Undiagnosed HIV and Hepatitis C infection in people who inject drugs: From new evidence to better practice. , 2017, Journal of substance abuse treatment.

[9]  D. D. Des Jarlais,et al.  Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention , 2017, PloS one.

[10]  M. Noroozi,et al.  Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran , 2017 .

[11]  P. Dítě,et al.  Prevalence of hepatitis C virus in adult population in the Czech Republic – time for birth cohort screening , 2017, PloS one.

[12]  Tony Smith,et al.  Rural people who inject drugs: A cross‐sectional survey addressing the dimensions of access to secondary needle and syringe program outlets , 2017, The Australian journal of rural health.

[13]  R. Garfein,et al.  Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California. , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  M. Dudas,et al.  HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden. , 2017, The International journal on drug policy.

[15]  R. Garfein,et al.  Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. , 2017, The International journal on drug policy.

[16]  P. Sadhukhan,et al.  Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  Polina Girchenko,et al.  Correlates of Double Risk of HIV Acquisition and Transmission Among Women who Inject Drugs in St. Petersburg, Russia , 2017, AIDS and Behavior.

[18]  W. Zule,et al.  Gender disparities in HIV prevalence and risk behaviors among people who inject drugs in Tajikistan , 2017 .

[19]  W. Ou,et al.  Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population , 2017, Journal of gastroenterology and hepatology.

[20]  D. Celentano,et al.  Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India , 2017, PloS one.

[21]  J. Canales,et al.  Influence of Peer-Based Needle Exchange Programs on Mental Health Status in People Who Inject Drugs: A Nationwide New Zealand Study , 2017, Front. Psychiatry.

[22]  V. Rees,et al.  Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: A cross-sectional study of two distinct populations in USA. , 2017, The International journal on drug policy.

[23]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[24]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[25]  H. Janson,et al.  High Perineal and Overall Frequency of Staphylococcus aureus in People Who Inject Drugs, Compared to Non-Injectors , 2016, Current Microbiology.

[26]  K. Stone.  Global state of harm reduction 2016. , 2016 .

[27]  Declan T. Barry,et al.  Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. , 2016, Addiction.

[28]  R. Kumar,et al.  Injection drug use among children and adolescents in India: Ringing the alarm bells , 2016, Indian journal of psychiatry.

[29]  M. Alary,et al.  Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network , 2016, Sexually transmitted diseases.

[30]  J. Arapović,et al.  HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina. , 2016, Journal of infection in developing countries.

[31]  F. Altice,et al.  The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia , 2016, The Lancet.

[32]  J. Rich,et al.  Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis , 2016, The Lancet.

[33]  B. Moazen,et al.  Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners , 2016, The Lancet.

[34]  N. Bannert,et al.  High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14) , 2016, BMC Public Health.

[35]  D. D. Des Jarlais,et al.  Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[36]  M. Jauffret-Roustide,et al.  Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey. , 2016, Revue d'epidemiologie et de sante publique.

[37]  C. von Hippel,et al.  Internalized Stigma Among People Who Inject Drugs , 2016, Substance use & misuse.

[38]  F. Altice,et al.  Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy , 2016, Journal of the International AIDS Society.

[39]  K. Poudel,et al.  Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal. , 2016, The International journal on drug policy.

[40]  D. D. Des Jarlais,et al.  Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. , 2016, The International journal on drug policy.

[41]  M. Čivljak,et al.  HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys. , 2016, The International journal on drug policy.

[42]  D. Sun,et al.  [HCV infection status and related risk factors in drug users under HIV sentinel surveillance in Henan province, 2011-2015]. , 2016, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[43]  G. Robinson,et al.  Prevalence of hepatitis C among injecting drug users attending drug clinics. , 2016, The New Zealand medical journal.

[44]  D. Prybylski,et al.  HIV prevalence and risk behaviors among people who inject drugs in Songkhla, Thailand: A respondent-driven sampling survey. , 2016, The International journal on drug policy.

[45]  R. Heimer,et al.  Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut. , 2016, Drug and alcohol review.

[46]  K. Deuba.  Poor condom-negotiation skills, inadequate social support, depression and incarceration associated with HIV risks among young key populations in Nepal , 2016 .

[47]  L. Bekker,et al.  HIV prevalence and risk among people who inject drugs in five South African cities. , 2016, The International journal on drug policy.

[48]  R. Bluthenthal,et al.  Food insecurity among people who inject drugs in Los Angeles and San Francisco , 2016, Public Health Nutrition.

[49]  R. Abadie,et al.  Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico , 2016, Harm Reduction Journal.

[50]  A. Štulhofer,et al.  HIV and HCV prevalence and incarceration-related risks among injecting drug users in three West Bank governorates , 2016, AIDS care.

[51]  Vikas Sharma,et al.  RATE OF ADHERENCE TO AND FACTORS ASSOCIATED WITH METHADONE MAINTENANCE TREATMENT PROGRAM (MMTP) COMPLIANCE AMONG INJECTING DRUG USE PATIENTS IN NEPAL. , 2016, The Southeast Asian journal of tropical medicine and public health.

[52]  B. Fischer,et al.  Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany. , 2016, The International journal on drug policy.

[53]  M. Vaezjalali,et al.  Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran , 2016, Hepatitis monthly.

[54]  S. Marashi,et al.  Prevalence of human herpesvirus-8 among HIV-infected patients, intravenous drug users and the general population in Iran. , 2016, Sexual health.

[55]  B. Sunguya,et al.  A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania , 2016, PloS one.

[56]  A. Impinen,et al.  Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan , 2016, Harm Reduction Journal.

[57]  M. Medina-Mora,et al.  Risk of violence in drug rehabilitation centers: perceptions of people who inject drugs in Tijuana, Mexico , 2016, Substance Abuse Treatment, Prevention, and Policy.

[58]  M. Suresh Kumar,et al.  Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India , 2016, PloS one.

[59]  S. Friedman,et al.  Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention , 2016, Substance use & misuse.

[60]  Sadia Majeed,et al.  Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study , 1969, Pakistan journal of medical sciences.

[61]  O. Levina,et al.  Emergence of methadone as a street drug in St. Petersburg, Russia. , 2016, The International journal on drug policy.

[62]  C. Latkin,et al.  Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs. , 2016, The International journal on drug policy.

[63]  R. Booth,et al.  Krokodile Injectors in Ukraine: Fueling the HIV Epidemic? , 2016, AIDS and Behavior.

[64]  D. D. Jarlais,et al.  Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic” , 2016, AIDS and Behavior.

[65]  R. D. Bruce,et al.  Epidemiology of Drug Use and HIV-Related Risk Behaviors among People Who Inject Drugs in Mwanza, Tanzania , 2015, PloS one.

[66]  M. Schaub,et al.  Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection , 2015, European Addiction Research.

[67]  D. D. Des Jarlais,et al.  HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya , 2015, Journal of acquired immune deficiency syndromes.

[68]  N. Dhingra,et al.  HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  S. Liang,et al.  Geographical variations of risk factors associated with HCV infection in drug users in southwestern China , 2015, Epidemiology and Infection.

[70]  M. Tyndall,et al.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada , 2015, Harm Reduction Journal.

[71]  G. Armstrong,et al.  Social context, diversity and risk among women who inject drugs in Vietnam: descriptive findings from a cross-sectional survey , 2015, Harm Reduction Journal.

[72]  A. Kral,et al.  Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden , 2015, Substance use & misuse.

[73]  Hossain Kj,et al.  Hepatitis-B Infections among the Injection Drug Abusers: An Emerging Risk in Public Health, Bangladesh. , 2015 .

[74]  Forrest W. Crawford,et al.  HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling , 2015, AIDS and Behavior.

[75]  G. Burnham,et al.  Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan , 2015, Harm Reduction Journal.

[76]  K. Dolan,et al.  P11.25 Timor-leste national size estimates and behavioural data for key populations at risk of hiv and other stis , 2015 .

[77]  Don C Des Jarlais,et al.  Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. , 2015, Addiction.

[78]  R. Westergaard,et al.  High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. , 2015, Drug and alcohol dependence.

[79]  N. Nebhinani,et al.  Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India , 2015, The Indian journal of medical research.

[80]  S. Moses,et al.  Monitoring HIV Prevention Programme Outcomes among Key Populations in Kenya: Findings from a National Survey , 2015, PloS one.

[81]  S. Dixit,et al.  Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal , 2015, PloS one.

[82]  S. Sherman,et al.  Police Encounters Among Needle Exchange Clients in Baltimore: Drug Law Enforcement as a Structural Determinant of Health. , 2015, American journal of public health.

[83]  Maria R Khan,et al.  Gender differences in planning ability and hepatitis C virus among people who inject drugs. , 2015, Addictive behaviors.

[84]  Georgios K Nikolopoulos,et al.  Network Characteristics of People Who Inject Drugs Within a New HIV Epidemic Following Austerity in Athens, Greece , 2015, Journal of acquired immune deficiency syndromes.

[85]  I. Thior,et al.  HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India , 2015, BMC Public Health.

[86]  N. Budambula,et al.  Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya , 2015, BMC Infectious Diseases.

[87]  B. Ogutu,et al.  Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast , 2015, PloS one.

[88]  M. Kanato.  Size Estimation of Injecting Drug Users through the Network Scale-Up Method in Thailand. , 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[89]  D. Vlahov,et al.  Incarceration and injection drug use in Baltimore, Maryland. , 2015, Addiction.

[90]  D. D. Des Jarlais,et al.  Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. , 2015, Drug and alcohol dependence.

[91]  A. Alshomrani,et al.  Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infection among heroin injectors in the central region of Saudi Arabia , 2015, Saudi medical journal.

[92]  T. Prevost,et al.  Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland , 2015, Addiction.

[93]  M. Dudas,et al.  Emerging Risks Due to New Injecting Patterns in Hungary During Austerity Times , 2015, Substance use & misuse.

[94]  H. Wedemeyer,et al.  P043: Injecting drug users (IDUs) are prone to Hepatitis B because of the high risk behaviour. Hepatitis B can be prevented through vaccines but the IDUs and their sexual partners from Kathmandu, Nepal are not getting preventive hepatitis B vaccinations , 2015 .

[95]  S. Moreea,et al.  PTU-118 An audit of the prevalence of chronic hepatitis c and treatment outcomes in drug users attending substance misuse centres in bradford – planning for future service provision , 2015 .

[96]  J. Lau,et al.  Prevalence of depressive symptoms and associated factors among people who inject drugs in China. , 2015, Drug and alcohol dependence.

[97]  S. Strathdee,et al.  Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention. , 2015, Drug and alcohol dependence.

[98]  S. Shoptaw,et al.  Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions , 2015, Journal of acquired immune deficiency syndromes.

[99]  M. Khalili,et al.  Relationship Between Psychiatric Distress and Criminal History Among Intravenous Drug Abusers in Iran , 2015, Iranian journal of psychiatry and behavioral sciences.

[100]  W. Zule,et al.  Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City , 2015, Harm Reduction Journal.

[101]  S. Allen,et al.  Using Capture-Recapture Methods to Estimate the Population of People Who Inject Drugs in Washington, DC , 2015, AIDS and Behavior.

[102]  E. Sigurdsson,et al.  Prevalent Intravenous Abuse of Methylphenidate Among Treatment-Seeking Patients With Substance Abuse Disorders: A Descriptive Population-Based Study , 2015, Journal of addiction medicine.

[103]  C. Latkin,et al.  Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam , 2015, European journal of gastroenterology & hepatology.

[104]  E. Collazo.  Healthcare service access, sexual aggression experiences, and HIV-related risk behaviors among Puerto Rican female intravenous drug users , 2015 .

[105]  Khodabakhsh Ahmadi,et al.  Socio-Economic Status Determines Risk of Receptive Syringe Sharing Behaviors among Iranian Drug Injectors; A National Study , 2015, Front. Psychiatry.

[106]  Elizabeth L. Ogburn,et al.  High HIV burden among people who inject drugs in 15 Indian cities , 2015, AIDS.

[107]  G. Dore,et al.  Hepatitis C virus therapeutic development: in pursuit of "perfectovir". , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  M. Clatts,et al.  Injection and sexual risk practices among young heroin users in Hanoi, Vietnam , 2015, Drugs.

[109]  J. Mahanta,et al.  Sexual behaviours of men who inject drugs in Northeast India , 2015, Harm Reduction Journal.

[110]  S. Whitehead,et al.  Diverse HIV epidemics among people who inject drugs in Thailand: evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai. , 2015, Drug and alcohol dependence.

[111]  M. Rosińska,et al.  High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance , 2015, BMC Infectious Diseases.

[112]  Hoang Thi Thanh Ha,et al.  Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) — Vietnam, 2009–2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus , 2015, PloS one.

[113]  F. Lespérance,et al.  Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role? , 2015, Drug and alcohol dependence.

[114]  Jasmina Burdzovic Andreas,et al.  Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses. , 2015, Drug and alcohol dependence.

[115]  S. Vermund,et al.  Methadone Maintenance Therapy and HIV Counseling and Testing are Associated with Lower frequency of Risky Behaviors Among Injection Drug Users in China , 2015, Substance use & misuse.

[116]  S. Friedman,et al.  Formal and Informal Organizational Activities of People Who Inject Drugs in New York City: Description and Correlates , 2015, Journal of addictive diseases.

[117]  Pierre-Marie Girard,et al.  Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study , 2015, Journal of the International AIDS Society.

[118]  R. Kumar,et al.  High Risk Behaviors of Injecting Drug Users (IDUs) in Chandigarh , 2015 .

[119]  S. Novak,et al.  The misuse, abuse and diversion of opioid replacement therapies among street abusers , 2015 .

[120]  Zunyou Wu,et al.  Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. , 2015, Addiction.

[121]  A. Ambekar,et al.  Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs. , 2015, Drug and alcohol review.

[122]  E. Wood,et al.  Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand. , 2015, Drug and alcohol review.

[123]  V. Reyes-Ortiz.  Social Network Correlates of HCV and HIV Transmission Risk Behaviors among Injecting Drug Users , 2015 .

[124]  O. Laeyendecker,et al.  Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study. , 2015, The Lancet. Infectious diseases.

[125]  G. Rutherford,et al.  High HIV Prevalence in a Respondent-Driven Sampling Survey of Injection Drug Users in Tehran, Iran , 2015, AIDS and Behavior.

[126]  M. Bleda,et al.  Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[127]  A. Haghdoost,et al.  Risk and vulnerability of key populations to HIV infection in Iran; knowledge, attitude and practises of female sex workers, prison inmates and people who inject drugs. , 2014, Sexual health.

[128]  H. Raymond,et al.  HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling , 2014, AIDS and Behavior.

[129]  E. Bishton,et al.  Screening for hepatitis C in injecting and ex-injecting drug users in North East Essex. , 2014, Public health.

[130]  B. Marshall,et al.  Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark , 2014, Harm Reduction Journal.

[131]  J. Zibbell,et al.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. , 2014, American journal of public health.

[132]  J. Zu,et al.  [Survey of Hepatitis B infection and vaccination status among drug users in Xi'an]. , 2014, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[133]  S. Assanangkornchai,et al.  Risk Behaviors, Prevalence of HIV and Hepatitis C Virus Infection and Population Size of Current Injection Drug Users in a China-Myanmar Border City: Results from a Respondent-Driven Sampling Survey in 2012 , 2014, PloS one.

[134]  R. Paranjape,et al.  An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India. , 2014, The International journal on drug policy.

[135]  R. Bluthenthal,et al.  Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source. , 2014, The International journal on drug policy.

[136]  N. Luhmann,et al.  Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment. , 2014, The International journal on drug policy.

[137]  I. Atherton,et al.  Prevalence of skin problems and leg ulceration in a sample of young injecting drug users , 2014, Harm Reduction Journal.

[138]  L. Køber,et al.  Echocardiographic findings suggestive of infective endocarditis in asymptomatic Danish injection drug users attending urban injection facilities. , 2014, The American journal of cardiology.

[139]  R. D. Bruce,et al.  Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[140]  S. Panda,et al.  Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates , 2014, International journal of STD & AIDS.

[141]  Heino Stöver,et al.  SMOKE IT! Promoting a change of opiate consumption pattern - from injecting to inhaling , 2014, Harm Reduction Journal.

[142]  J. Volk,et al.  HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran , 2014, AIDS care.

[143]  V. Stefanovska,et al.  Patients on Opioid Substitution Treatment in the Republic of Macedonia: What Do Treatment Demand Data Tell Us? , 2014 .

[144]  Anuradha Sharma,et al.  Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency viruses amongst Injecting Drug Users in Mumbai,India. , 2014, Journal of clinical and diagnostic research : JCDR.

[145]  R. D. Bruce,et al.  Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[146]  A. Bretteville-Jensen,et al.  Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users , 2014, BMC Public Health.

[147]  Hongyun Fu,et al.  Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces , 2014, Harm Reduction Journal.

[148]  A. Noroozi,et al.  Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran , 2014, International journal of STD & AIDS.

[149]  M. Stein,et al.  Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users , 2014, AIDS and Behavior.

[150]  A. Widell,et al.  Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy—Factors associated with advanced fibrosis , 2014, Scandinavian journal of infectious diseases.

[151]  Ross J. Harris,et al.  Recapture or Precapture? Fallibility of Standard Capture-Recapture Methods in the Presence of Referrals Between Sources , 2014, American journal of epidemiology.

[152]  O. Laeyendecker,et al.  O34 LIMITED ACCESS TO HCV TESTING AND TREATMENT AMONG INJECTION DRUG USERS ACROSS INDIA , 2014 .

[153]  Mehdi Mohammadzadeh,et al.  Size Estimation of Most-at-Risk Groups of HIV/AIDS Using Network Scale-up in Tabriz, Iran , 2014 .

[154]  M. Rotondi,et al.  Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. , 2014, Drug and alcohol dependence.

[155]  M. Sternberg,et al.  Prevalence of HIV, Sexually Transmitted Infections, and Viral Hepatitis by Urbanicity, Among Men Who Have Sex With Men, Injection Drug Users, and Heterosexuals in the United States , 2014, Sexually transmitted diseases.

[156]  S. Darke,et al.  The association of childhood physical abuse with the onset and extent of drug use among regular injecting drug users. , 2014, Addiction.

[157]  I. Grant,et al.  Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. , 2014, Drug and alcohol dependence.

[158]  Nguyen Le Minh,et al.  Community-Level Income Inequality and HIV Prevalence among Persons Who Inject Drugs in Thai Nguyen, Vietnam , 2014, PloS one.

[159]  E. Finch,et al.  Association of higher-risk alcohol consumption with injecting paraphernalia sharing behaviours in intravenous drug users , 2014, The American journal of drug and alcohol abuse.

[160]  R. Mattick,et al.  The diversion and injection of a buprenorphine-naloxone soluble film formulation. , 2014, Drug and alcohol dependence.

[161]  M. Brugal,et al.  Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). , 2014, Adicciones.

[162]  M. Brugal,et al.  Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs. , 2014, Gaceta sanitaria.

[163]  J. Bryant,et al.  A study of young people who inject drugs: an opportunity to decrease high risk injecting by improving knowledge about hepatitis C prevention , 2014 .

[164]  J. Wylie,et al.  Outlier Populations: Individual and Social Network Correlates of Solvent-Using Injection Drug Users , 2014, PloS one.

[165]  C. Latkin,et al.  Social Network Structure and HIV Infection Among Injecting Drug Users in Lithuania: Gatekeepers as Bridges of Infection , 2014, AIDS and Behavior.

[166]  Antony M. Overstall,et al.  Estimating prevalence of injecting drug users and associated heroin‐related death rates in England by using regional data and incorporating prior information , 2014 .

[167]  M. Javanbakht,et al.  Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran , 2014, Iranian Red Crescent medical journal.

[168]  Khodabakhsh Ahmadi,et al.  Having Multiple Sexual Partners among Iranian Intra-Venous Drug Users , 2013, Front. Psychiatry.

[169]  Khodabakhsh Ahmadi,et al.  Drug Injection to Sites other than Arm: A Study of Iranian Heroin Injectors , 2013, Front. Psychiatry.

[170]  R. Testa,et al.  Prevalence of HCV infection and adherence to DOT therapy in Italian and non-Italian IV drug users in Rome, Italy , 2014 .

[171]  C. Behrends.  Evaluating the Impact of Satellite Syringe Exchange on Reducing HIV Risk Behavior and Seroconversion among People who Inject Drugs , 2014 .

[172]  K. Kliiman,et al.  Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. , 2014, The International journal on drug policy.

[173]  M. Hellard,et al.  Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. , 2014, The International journal on drug policy.

[174]  R. Heimer,et al.  Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA , 2014, AIDS and Behavior.

[175]  C. Li,et al.  Psychometric properties of the World Health Organization quality of life assessment – brief in methadone patients: a validation study in northern Taiwan , 2013, Harm Reduction Journal.

[176]  M. Moghadami,et al.  Blood-Borne Hepatitis in Opiate Users in Iran: A Poor Outlook and Urgent Need to Change Nationwide Screening Policy , 2013, PloS one.

[177]  J. Sachdeva,et al.  Seroprevalence of human immunodeficiency virus, hepatitis B surface antigen, and hepatitis C in substance dependents admitted in a tertiary hospital at Amritsar, India. , 2013, Asian journal of psychiatry.

[178]  A. Bretteville-Jensen,et al.  Is opioid substitution treatment beneficial if injecting behaviour continues? , 2013, Drug and alcohol dependence.

[179]  Lei Zhang,et al.  High Prevalence of HIV, HCV and Tuberculosis and Associated Risk Behaviours among New Entrants of Methadone Maintenance Treatment Clinics in Guangdong Province, China , 2013, PloS one.

[180]  O. Levina,et al.  Moderate/heavy alcohol use and HCV infection among injection drug users in two Russian cities. , 2013, Drug and alcohol dependence.

[181]  J. Rich,et al.  Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta‐analysis , 2013, Hepatology.

[182]  I. Thior,et al.  Strategies for recruiting injection drug users for HIV prevention services in Delhi, India , 2013, Harm Reduction Journal.

[183]  A. Haghdoost,et al.  HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey , 2013, Sexually Transmitted Infections.

[184]  S. Torabian,et al.  Latent and Active Tuberculosis: Evaluation of Injecting Drug Users , 2013, Iranian Red Crescent medical journal.

[185]  J. Busza,et al.  Injecting behaviour and service use among young injectors in Albania, Moldova, Romania and Serbia. , 2013, The International journal on drug policy.

[186]  Yan-lin Tao,et al.  Prevalence of hepatitis C infection among intravenous drug users in Shanghai. , 2013, World journal of gastroenterology.

[187]  S. Adebajo,et al.  Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria , 2013, International journal of STD & AIDS.

[188]  Hui-Yi Lin,et al.  Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China. , 2013, AIDS education and prevention : official publication of the International Society for AIDS Education.

[189]  S. Alavian,et al.  Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users , 2013, Hepatitis monthly.

[190]  M. Rosińska,et al.  Refining HIV Risk: The Modifying Effects of Youth, Gender and Education among People Who Inject Drugs in Poland , 2013, PloS one.

[191]  A. Boci,et al.  P3.096 HIV and HCV Prevalence and Risky Behaviors Among Needle Exchange Program Users in Albania , 2013, Sexually Transmitted Infections.

[192]  M. Poljak,et al.  P3.320 Unlinked Anonymous Testing For Monitoring HIV Prevalence in Sentinel Groups in Slovenia, 2002–2011 , 2013, Sexually Transmitted Infections.

[193]  D. Yadav.  P3.195 Burden of Hepatitis ‘C’ Among High Risk People of HIV/IV Drug Users: A Community Based Study from Eastern Nepal , 2013, Sexually Transmitted Infections.

[194]  A. Uusküla,et al.  P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia , 2013, Sexually Transmitted Infections.

[195]  D. D. Des Jarlais,et al.  A decline in the prevalence of injecting drug users in Estonia, 2005-2009. , 2013, The International journal on drug policy.

[196]  R. D. Bruce,et al.  Identifying Programmatic Gaps: Inequities in Harm Reduction Service Utilization among Male and Female Drug Users in Dar es Salaam, Tanzania , 2013, PloS one.

[197]  C. Aitken,et al.  Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results , 2013, Harm Reduction Journal.

[198]  M. Yen,et al.  Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus tuberculin skin test , 2013, Scandinavian journal of infectious diseases.

[199]  H. Raymond,et al.  Estimates of the size of key populations at risk for HIV infection: men who have sex with men, female sex workers and injecting drug users in Nairobi, Kenya , 2013, Sexually Transmitted Infections.

[200]  M. Sarbazi,et al.  Epidemiological features of hepatitis B and C infection in a high risk population: results of screening programs , 2013, Gastroenterology and hepatology from bed to bench.

[201]  Enrique R. Pouget,et al.  Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992–2007 , 2013, PloS one.

[202]  Ning Wang,et al.  [HCV prevalence among the populations under the HIV sentinel surveillance data from 2009 to 2012 in China]. , 2013, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[203]  M. Jimba,et al.  What are the factors associated with HIV testing among male injecting and non-injecting drug users in Lashio, Myanmar: a cross-sectional study , 2013, BMJ Open.

[204]  O. Levina,et al.  Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study , 2013, BMJ Open.

[205]  Anthony F Jorm,et al.  Quality of life, depression, anxiety and suicidal ideation among men who inject drugs in Delhi, India , 2013, BMC Psychiatry.

[206]  H. Keyvani,et al.  Reduction in Prevalence of Hepatitis B Surface Antigen Among Intravenous Drug Users in Tehran Drop-in-Centers , 2013 .

[207]  A. A. Turki,et al.  New Evidence on the HIV Epidemic in Libya: Why Countries Must Implement Prevention Programs Among People Who Inject Drugs , 2013, Journal of acquired immune deficiency syndromes.

[208]  M. Torrens,et al.  HIV Infection and Viral Hepatitis in Drug Abusers , 2013 .

[209]  Min Kwon,et al.  Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea , 2013, Journal of medical virology.

[210]  Z. Demetrovics,et al.  Transition to injecting 3,4-methylene-dioxy-pyrovalerone (MDPV) among needle exchange program participants in Hungary , 2013, Journal of psychopharmacology.

[211]  N. Wong,et al.  A multilevel approach for assessing the variability of hepatitis C prevalence in injection drug users by their gathering places. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[212]  D. Basu,et al.  Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users. , 2013, Asian journal of psychiatry.

[213]  J. Bryant,et al.  Harm reduction knowledge and information exchange among secondary distributors in Sydney, Australia , 2013 .

[214]  C. Archibald,et al.  Geographical and temporal variation of injection drug users in Pakistan , 2013, Sexually Transmitted Infections.

[215]  M. Brugal,et al.  Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain. , 2013, Gaceta sanitaria.

[216]  Ciaran J Jennings.  Re-establishing Contact: A profile of clients attending the health promotion unit - needle exchange at Merchants Quay Ireland. , 2013 .

[217]  J. Havens,et al.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. , 2013, American journal of public health.

[218]  N. Luhmann,et al.  An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011. , 2013, The International journal on drug policy.

[219]  A. Khatib,et al.  Estimating the Number of People Who Inject Drugs, Female Sex Workers, and Men Who Have Sex with Men, Unguja Island, Zanzibar: Results and Synthesis of Multiple Methods , 2013, AIDS and Behavior.

[220]  R. Garfein,et al.  HCV Infection Prevalence Lower Than Expected among 18–40-Year-Old Injection Drug Users in San Diego, CA , 2013, Journal of Urban Health.

[221]  M. A. Toori,et al.  Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran , 2012, BMC Infectious Diseases.

[222]  B. Mahapatra,et al.  Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India , 2012, Harm Reduction Journal.

[223]  K. Rudzinski,et al.  Frequent food insecurity among injection drug users: correlates and concerns , 2012, BMC Public Health.

[224]  M. Berglund,et al.  Respondent-driven sampling in a syringe exchange setting , 2012, Scandinavian journal of public health.

[225]  K. Rüütel,et al.  Tuberculosis knowledge among injecting drug users visiting syringe exchange programme in Tallinn, Estonia. , 2012, Central European journal of public health.

[226]  M. Hellard,et al.  Uptake of paraphernalia from injecting equipment provision services and its association with sharing of paraphernalia among injecting drug users in Scotland. , 2012, Drug and alcohol dependence.

[227]  S. Verma,et al.  Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers , 2012, Journal of medical virology.

[228]  Garry Robins,et al.  Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs , 2012, PloS one.

[229]  R. Garfein,et al.  HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010 , 2012, The American journal of drug and alcohol abuse.

[230]  R. Paranjape,et al.  Factors associated with ever HIV testing among injecting drug users (IDUs) in two HIV high prevalent States of India , 2012 .

[231]  K. Rüütel,et al.  Piloting HIV rapid testing in community-based settings in Estonia , 2012, Scandinavian journal of public health.

[232]  V. Baćak,et al.  Hepatitis C Virus Infection and Related Risk Factors among Injection Drug Users in Montenegro , 2012, European Addiction Research.

[233]  N. Nurjannah,et al.  HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs , 2012, Harm Reduction Journal.

[234]  A. Sawitri,et al.  Estimating the number of the people who inject drugs in Bali, 2010. , 2012, Drug and alcohol review.

[235]  W. Liu,et al.  Controlling HIV Epidemics among Injection Drug Users: Eight Years of Cross-Border HIV Prevention Interventions in Vietnam and China , 2012, PloS one.

[236]  Yong-tang Zheng,et al.  High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China , 2012, PloS one.

[237]  Alain Origer.  Prevalence of Problem Drug Use and Injecting Drug Use in Luxembourg: A Longitudinal and Methodological Perspective , 2012, European Addiction Research.

[238]  E. Wood,et al.  Factors associated with methadone treatment among injection drug users in Bangkok, Thailand. , 2012, Journal of substance abuse treatment.

[239]  C. Duff,et al.  An examination of injection drug use trends in Victoria and Vancouver, BC after the closure of Victoria's only fixed-site needle and syringe programme. , 2012, The International journal on drug policy.

[240]  G. Donenberg,et al.  Prevalence of psychiatric disorders among young injection drug users. , 2012, Drug and alcohol dependence.

[241]  R. Schottenfeld,et al.  Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia. , 2012, Drug and alcohol dependence.

[242]  E. Geraghty,et al.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users. , 2012, American journal of epidemiology.

[243]  S. Friedman,et al.  Resilience Among IDUs: Planning Strategies to Help Injection Drug Users to Protect Themselves and Others From HIV/HCV Infections , 2012, Substance use & misuse.

[244]  S. Elofsson,et al.  [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study]. , 2012, Lakartidningen.

[245]  H. Wand,et al.  Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia , 2012, Journal of Urban Health.

[246]  S. Hutchinson,et al.  The association between alcohol use and hepatitis C status among injecting drug users in Glasgow. , 2012, Drug and alcohol dependence.

[247]  E. Regidor,et al.  Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. , 2012, Addiction.

[248]  L. Metsch,et al.  A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs. , 2012, Drug and alcohol dependence.

[249]  C. Yen,et al.  Self-efficacy and HIV risk behaviors among heroin users in Taiwan. , 2012, Journal of studies on alcohol and drugs.

[250]  D. Lewis,et al.  Assessment of unsafe injection practices and sexual behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. , 2012, The Southeast Asian journal of tropical medicine and public health.

[251]  L. Hwang,et al.  Human Immunodeficiency Virus, Hepatitis B and Hepatitis C Virus Infections Among Injecting and Non-Injecting Drug Users in Inner City Neighborhoods , 2012 .

[252]  J. Rich,et al.  Syringe Acquisition Experiences and Attitudes among Injection Drug Users Undergoing Short-Term Opioid Detoxification in Massachusetts and Rhode Island , 2012, Journal of Urban Health.

[253]  Ľ. Okruhlica,et al.  [The seroprevalence of HCV among injecting drug users in the years 2004-2008 in Slovakia]. , 2012, Vnitrni lekarstvi.

[254]  K. Heidari,et al.  Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran , 2012, International journal of preventive medicine.

[255]  Y. Hser,et al.  Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. , 2012, Journal of public health.

[256]  B. Ataei,et al.  High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs , 2012, International journal of preventive medicine.

[257]  B. Akoijam,et al.  Size estimation of injecting drug users (IDU) using multiplier method in five Districts of India , 2012, Substance Abuse Treatment, Prevention, and Policy.

[258]  D. Kerrigan,et al.  The Impact of Human Rights Violations and Perceptions of Discrimination on Health Service Utilization Among Injection Drug Users in Delhi, India , 2012, Substance use & misuse.

[259]  A. Rahimi-Movaghar,et al.  Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran , 2012, Hepatitis monthly.

[260]  R. Callaghan,et al.  Prince George 2012 I-Track Survey Results: Findings and Discussion , 2012 .

[261]  David Barry,et al.  The journey into injecting heroin use. , 2012 .

[262]  J. Biswas,et al.  Prevalence of human papillomavirus and co-existent sexually transmitted infections among female sex workers, men having sex with men and injectable drug abusers from eastern India. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[263]  F. Serre,et al.  Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy , 2012, AIDS and Behavior.

[264]  J. Bryant,et al.  Syringe Coverage in an Australian Setting: Does a High Level of Syringe Coverage Moderate Syringe Sharing Behaviour? , 2012, AIDS and Behavior.

[265]  Kavita Singh,et al.  A Venue-Based Approach to Reaching MSM, IDUs and the General Population with VCT: A Three Study Site in Kenya , 2012, AIDS and Behavior.

[266]  M. Golden,et al.  Prevalence and Characteristics of Femoral Injection among Seattle-Area Injection Drug Users , 2012, Journal of Urban Health.

[267]  G. Armstrong,et al.  HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme , 2011, BMC public health.

[268]  Kavita Singh,et al.  Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study. , 2011, Drug and alcohol dependence.

[269]  D. D. Des Jarlais,et al.  Role of Sexual Transmission of HIV Among Young Noninjection and Injection Opiate Users: A Respondent-Driven Sampling Study , 2011, Sexually transmitted diseases.

[270]  A. Widell,et al.  Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program , 2011, Journal of viral hepatitis.

[271]  N. Subramanian.  Treatment and care for older drug users , 2011, Irish Journal of Psychological Medicine.

[272]  T. Neilands,et al.  Assessing geographic and individual level factors associated with arrests among injection drug users in California. , 2011, Health & place.

[273]  J. Bell,et al.  Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. , 2011, Drug and alcohol dependence.

[274]  Erin E. Bonar,et al.  Using the health belief model to predict injecting drug users' intentions to employ harm reduction strategies. , 2011, Addictive behaviors.

[275]  M. Bravo,et al.  Estimating the prevalence of drug injection using a multiplier method based on a register of new HIV diagnoses. , 2011, European journal of public health.

[276]  B. Kolarić.  Croatia: still a low-level HIV epidemic?--seroprevalence study. , 2011, Collegium antropologicum.

[277]  D. Naber,et al.  Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. , 2011, Addiction.

[278]  J. Rich,et al.  Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users , 2011, Journal of addiction medicine.

[279]  D. Vlahov,et al.  Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment , 2011, Harm reduction journal.

[280]  J. Reimer,et al.  Factors Associated With Suicide Attempts Among Injection Drug Users , 2011, Substance use & misuse.

[281]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[282]  M. Hellard,et al.  The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users , 2011, The Medical journal of Australia.

[283]  C. Vagu,et al.  Hepatitis C virus genotypes in injecting drug users from Romania , 2011, Central European journal of medicine.

[284]  Paul Sandstrom,et al.  Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs , 2011, PloS one.

[285]  L. Johnston,et al.  High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. , 2011, The International journal on drug policy.

[286]  J. D. de Wit,et al.  Conducting a respondent-driven sampling survey with the use of existing resources in Sydney, Australia. , 2011, Drug and alcohol dependence.

[287]  Erin K. Gibson,et al.  A mixed methods approach to delineating and understanding injection practices among clientele of a Victoria, British Columbia needle exchange program. , 2011, Drug and alcohol review.

[288]  I. Bozicevic,et al.  Unsafe Injection and Sexual Risk Behavior among Injecting Drug Users in Georgia , 2011, Journal of Urban Health.

[289]  M. Lemstra,et al.  Risk Indicators of Depressive Symptomatology among Injection Drug Users and Increased HIV Risk Behaviour , 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[290]  E. Wood,et al.  Methamphetamine injection and syringe sharing among a community-recruited sample of injection drug users in Bangkok, Thailand. , 2011, Drug and alcohol dependence.

[291]  F. Amirian,et al.  PREVALENCE AND ASSOCIATED FACTORS OF HEPATITIS C IN SELF-INTRODUCED SUBSTANCE ABUSERS , 2011 .

[292]  T. Lee,et al.  Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan , 2011, Substance abuse treatment, prevention, and policy.

[293]  R. Calado,et al.  Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal , 2011, Journal of medical virology.

[294]  J. Parry,et al.  Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots , 2011, Journal of viral hepatitis.

[295]  S. Deren,et al.  HIV and Drug Use in Puerto Rico , 2011, Journal of the International Association of Physicians in AIDS Care.

[296]  A. Shoghli,et al.  Behavioral Surveillance Survey (BSS) Among Injection Drug Users (IDUs) in Zanjan-Iran , 2011 .

[297]  Jerome H. Kim,et al.  Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[298]  R. Atun,et al.  Sex, drugs and economic behaviour in Russia: a study of socio-economic characteristics of high risk populations. , 2011, The International journal on drug policy.

[299]  B. Kolarić,et al.  Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia. , 2011, Central European journal of public health.

[300]  D. Vlahov,et al.  Changes in blood-borne infection risk among injection drug users. , 2011, The Journal of infectious diseases.

[301]  M. Berglund,et al.  Efficacy of mobile telephone contact for follow-up in injecting heroin users , 2011, The American journal of drug and alcohol abuse.

[302]  C. J. Thomas,et al.  Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India , 2011, BMC public health.

[303]  Yong-tang Zheng,et al.  Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region , 2011, PloS one.

[304]  D. Vlahov,et al.  Comparison of HIV Risk by Duration of Injection Drug Use , 2011, Substance use & misuse.

[305]  R. Heimer,et al.  Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic , 2010, European journal of public health.

[306]  Yaran Majid,et al.  HEPATITIS C SCREENING IN ISFAHAN DROP IN CENTERS: AN EXPERIENCE DESCRIPTION , 2011 .

[307]  S. McCurdy,et al.  hiV riSK BehAViourS, PerceiVeD SeVeritY of Drug uSe ProBleMS, AnD Prior treAtMent eXPerience in A SAMPle of Young heroin inJec- torS in DAr eS SAlAAM, tAnZAniA , 2011 .

[308]  G. Hay,et al.  Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2009/10: Sweep 6 report , 2011 .

[309]  O. Levina,et al.  Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability , 2011, AIDS and Behavior.

[310]  Chyvette T. Williams,et al.  Crossing Over: Drug Network Characteristics and Injection Risk Along the China–Myanmar Border , 2011, AIDS and Behavior.

[311]  C. Maynard,et al.  Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges , 2011, Journal of Urban Health.

[312]  A. Nejatizadeh,et al.  Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B Virus in Iran , 2011, Archives of Virology.

[313]  Min Zhao,et al.  Patterns of Childhood Trauma and Psychological Distress among Injecting Heroin Users in China , 2010, PloS one.

[314]  G. Armstrong,et al.  Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action , 2010, Harm reduction journal.

[315]  R. Ahas,et al.  Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors , 2010, Sexually Transmitted Infections.

[316]  S. Strathdee,et al.  Prevalence and Correlates of Syphilis and Condom Use Among Male Injection Drug Users in Four Afghan Cities , 2010, Sexually transmitted diseases.

[317]  M. Meshkati,et al.  Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. , 2010, The International journal on drug policy.

[318]  M. Abrahamowicz,et al.  Availability of body art facilities and body art piercing do not predict hepatitis C acquisition among injection drug users in Montreal, Canada: Results from a cohort study. , 2010, The International journal on drug policy.

[319]  A. Joshi,et al.  Correlates of sharing injection equipment among male injecting drug users in Kathmandu, Nepal. , 2010, The International journal on drug policy.

[320]  Jinying Huang,et al.  Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China - a cross-sectional study , 2010, BMC public health.

[321]  S. Vermund,et al.  Prevalence and Correlates of Needle-Sharing Among New and Long-Term Injection Drug Users in Southwest China , 2010, Substance use & misuse.

[322]  J. Georgsen,et al.  Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users , 2010, Journal of medical virology.

[323]  J. Schmit,et al.  Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence , 2010, Journal of Epidemiology & Community Health.

[324]  S. Tafuri,et al.  Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence. , 2010, Journal of preventive medicine and hygiene.

[325]  S. Strathdee,et al.  Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan. , 2010, Journal of public health.

[326]  J. Parry,et al.  Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. , 2010, Journal of public health.

[327]  T. Rhodes,et al.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.

[328]  Z. Mahfoud,et al.  HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys , 2010, AIDS.

[329]  W. Mcfarland,et al.  Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. , 2010, Archives of Iranian medicine.

[330]  D. De Angelis,et al.  Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment , 2010, BMJ : British Medical Journal.

[331]  N. Geoghegan,et al.  What are the risk factors for soft tissue abscess development among injecting drug users? , 2010, Nursing times.

[332]  L. Lundgren,et al.  Needle Sharing Among Puerto Rican Injection Drug Users in Puerto Rico and Massachusetts: Place of Birth and Residence Matter , 2010, Substance use & misuse.

[333]  B. Kolarić,et al.  Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. , 2010, Central European journal of public health.

[334]  M. Schaub,et al.  Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine. , 2010, The International journal on drug policy.

[335]  Victoria González,et al.  [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia]. , 2010, Enfermedades infecciosas y microbiologia clinica.

[336]  A. Siregar,et al.  Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia. , 2010, Health policy.

[337]  Sekhar Chakraborti,et al.  HIV Infection and Host Genetic Mutation among Injecting Drug-users of Northeastern States of India , 2010, Journal of health, population, and nutrition.

[338]  E. Wood,et al.  High rates of midazolam injection among drug users in Bangkok, Thailand , 2010, Harm reduction journal.

[339]  D. Celentano,et al.  The Profile of Injection Drug Users in Chennai, India: Identification of Risk Behaviours and Implications for Interventions , 2010, Substance use & misuse.

[340]  L. Kostrikis,et al.  Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus , 2010, Journal of medical virology.

[341]  A. Rahimi-Movaghar,et al.  A follow-up study of drug users in Southern Iran , 2010 .

[342]  H. Moriarty,et al.  Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey. , 2009, Drug and alcohol review.

[343]  M. Gagnon,et al.  [Psychosocial determinants of drug users to use a new syringe]. , 2010, Revue d'epidemiologie et de sante publique.

[344]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[345]  T. Rhodes,et al.  HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. , 2010, The International journal on drug policy.

[346]  R. Brooner,et al.  Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures. , 2010, Journal of substance abuse treatment.

[347]  A. Rahimi-Movaghar,et al.  HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[348]  G. Rezza,et al.  Few Italian Drug Users Undergo HIV Testing , 2011, AIDS and Behavior.

[349]  M. Miovský,et al.  Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine? , 2009, European Addiction Research.

[350]  R. Booth,et al.  Interventions with injection drug users in Ukraine. , 2009, Addiction.

[351]  J. Mahanta,et al.  The risk of HIV and HCV infections among injection drug users in northeast India , 2009, AIDS care.

[352]  S. Davis,et al.  Survey of abuses against injecting drug users in Indonesia , 2009, Harm reduction journal.

[353]  A. Oyefeso,et al.  Injecting other users: A pilot study in an area of high prevalence of drug-related deaths , 2009 .

[354]  J. Carr,et al.  Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. , 2009, AIDS research and human retroviruses.

[355]  J. Parry,et al.  Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. , 2009, Journal of public health.

[356]  A. Hatzakis,et al.  Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users , 2009, Epidemiology and Infection.

[357]  H. Qian,et al.  HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey , 2009, Harm reduction journal.

[358]  S. Narayanan,et al.  The relative risk of HIV among IDUs not in treatment in Malaysia , 2009, AIDS care.

[359]  S. Sherman,et al.  Utilization patterns and correlates of retention among clients of the needle exchange program in Baltimore, Maryland. , 2009, Drug and alcohol dependence.

[360]  J. Parry,et al.  Measuring risk of HIV and HCV among injecting drug users in the Russian Federation. , 2009, European journal of public health.

[361]  M. Forouzanfar,et al.  Prevalence of HIV and Hepatitis C Virus Infections and Related Behavioral Determinants among Injecting Drug Users of Drop-in Centers in Iran , 2009 .

[362]  R. Wisaksana,et al.  Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia. , 2009, Acta medica Indonesiana.

[363]  T. Patterson,et al.  Polydrug Use among IDUs in Tijuana, Mexico: Correlates of Methamphetamine Use and Route of Administration by Gender , 2009, Journal of Urban Health.

[364]  C. Latkin,et al.  Correlates of Unsafe Equipment Sharing among Injecting Drug Users in St. Petersburg, Russia , 2009, European Addiction Research.

[365]  J. Amin,et al.  High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre , 2009, Australian and New Zealand journal of public health.

[366]  A. Douaihy,et al.  Access to Healthcare Among Injection Drug Users at a Needle Exchange Program in Pittsburgh, PA , 2009, Journal of addiction medicine.

[367]  J. Montaner,et al.  Determinants of cutaneous injection-related infection care at a supervised injecting facility. , 2009, Annals of epidemiology.

[368]  A. Neaigus,et al.  Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary. , 2009, European journal of public health.

[369]  C. Archibald,et al.  Factors Associated With an Explosive HIV Epidemic Among Injecting Drug Users in Sargodha, Pakistan , 2009, Journal of acquired immune deficiency syndromes.

[370]  M. Hellard,et al.  Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. , 2009, The Journal of infection.

[371]  M. Haugen,et al.  Living as a drug addict in Oslo, Norway – a study focusing on nutrition and health , 2009, Public Health Nutrition.

[372]  S. Mayhew,et al.  Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic , 2009, Sexually Transmitted Infections.

[373]  G. Bobashev,et al.  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. , 2009, Drug and alcohol dependence.

[374]  S. Abbas,et al.  High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. , 2009, JPMA. The Journal of the Pakistan Medical Association.

[375]  L. Johnston,et al.  Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro , 2009, BMC infectious diseases.

[376]  R Power,et al.  Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. , 2009, Drug and alcohol dependence.

[377]  Martin A. Weiss.  The African Development Bank Group , 2009 .

[378]  A. Karpati,et al.  The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City , 2009, Harm reduction journal.

[379]  Ferenc Márványkövi,et al.  Sex and Drugs: The Correlations of Injecting Drug Users' Risk Perception and Behavioral Patterns , 2009, Substance use & misuse.

[380]  D. Huo,et al.  Needle Exchange and Sexual Risk Behaviors Among a Cohort of Injection Drug Users in Chicago, Illinois , 2009, Sexually transmitted diseases.

[381]  H. Tsui,et al.  Prevalence of needle sharing, commercial sex behaviors and associated factors in Chinese male and female injecting drug user populations , 2009, AIDS care.

[382]  R. Booth,et al.  Predictors of Methamphetamine Injection in Out-of-Treatment IDUs , 2009, Substance use & misuse.

[383]  Wen Ming-xi.  Investigation into the AIDS knowledge,behavior and serological test among the drug users in Xiangfan , 2009 .

[384]  B. Kolarić,et al.  Risk behaviour and risk for HIV infection in population of injecting drug users. , 2009 .

[385]  H. Phan.  Hepatitis C and human immunodeficiency virus infections in injecting drug users in drug treatment centers in Vietnam , 2009 .

[386]  O. Pogarell,et al.  [Burden of disease and level of patient's medical care in substitution treatment for opiates]. , 2009, Medizinische Klinik.

[387]  O. Dalgard,et al.  [Risk factors for hepatitis C among injecting drug users in Oslo]. , 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[388]  M. Sayyah,et al.  Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan , 2009, Indian journal of sexually transmitted diseases and AIDS.

[389]  Greek Reitox.  New Development, Trends and in-depth information on selected issues , 2009 .

[390]  M. Gouya,et al.  Needle and Syringe Sharing Practices Among Injecting Drug Users in Tehran: A Comparison of Two Neighborhoods, One with and One Without a Needle and Syringe Program , 2010, AIDS and Behavior.

[391]  D. D. Des Jarlais,et al.  Hazardous Drinking and HIV Sexual Risk Behaviors Among Injection Drug Users in Developing and Transitional Countries , 2010, AIDS and Behavior.

[392]  Kimberly C. Brouwer,et al.  Deportation Along the U.S.–Mexico Border: Its Relation to Drug Use Patterns and Accessing Care , 2009, Journal of Immigrant and Minority Health.

[393]  R. Malekzadeh,et al.  Hepatitis C seroprevalence among intravenous drug users in Tehran , 2008 .

[394]  R. Paranjape,et al.  Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India , 2008, AIDS.

[395]  K. Dolan,et al.  Injecting drug users' understanding of hepatitis C. , 2008, Addictive behaviors.

[396]  M. Faruque,et al.  Prevalence of Infections, HIV Risk Behaviors and Factors Associated with HIV Infection Among Male Injecting Drug Users Attending a Needle/Syringe Exchange Program in Dhaka, Bangladesh , 2008, Substance use & misuse.

[397]  A. Winstock,et al.  Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. , 2008, The International journal on drug policy.

[398]  S. Strathdee,et al.  Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border , 2008, Harm reduction journal.

[399]  C. Latkin,et al.  High Prevalence of HIV, HIV/Hepatitis C Virus Coinfection, and Risk Behaviors Among Injection Drug Users in Chennai, India: A Cause for Concern , 2008, Journal of acquired immune deficiency syndromes.

[400]  J. Kaldor,et al.  Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. , 2008, Drug and alcohol review.

[401]  R. Dwyer,et al.  The oral health of street-recruited injecting drug users: prevalence and correlates of problems. , 2008, Addiction.

[402]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[403]  H. Tsui,et al.  Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. , 2008, Drug and alcohol dependence.

[404]  M. Ross,et al.  Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. , 2008, The American journal of tropical medicine and hygiene.

[405]  Daijin Kim,et al.  High prevalence of HBV and HCV infection among intravenous drug users in Korea , 2008, Journal of medical virology.

[406]  T. Chieochansin,et al.  Parvovirus 4 (PARV4) in Serum of Intravenous Drug Users and Blood Donors , 2008, Infection.

[407]  S. Vermund,et al.  Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: Community-based surveys along major drug trafficking routes , 2008, Harm reduction journal.

[408]  N. Saleem,et al.  Risky sexual behavior, knowledge of sexually transmitted infections and treatment utilization among a vulnerable population in Rawalpindi, Pakistan. , 2008, The Southeast Asian journal of tropical medicine and public health.

[409]  Lena Shah,et al.  Identifying heterogeneity among injection drug users: a cluster analysis approach. , 2008, American journal of public health.

[410]  C. Toro,et al.  Prevalence of and Risk Factors for Hepatitis B Virus Infection among Street-Recruited Young Injection and Non-Injection Heroin Users in Barcelona, Madrid and Seville , 2008, European Addiction Research.

[411]  C. Bond,et al.  Assessing and prioritizing the preferences of injecting drug users in needle and syringe exchange service development. , 2008, Journal of public health.

[412]  M. Kals,et al.  High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. , 2008, Journal of public health.

[413]  I. A. Chowdhury,et al.  Bangladesh Moves from Being a Low-Prevalence Nation for Hiv to One with a Concentrated Epidemic in Injecting Drug Users , 2008, International journal of STD & AIDS.

[414]  J. Hahn,et al.  Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. , 2008, Drug and alcohol review.

[415]  A. Baker,et al.  Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. , 2008, Drug and alcohol review.

[416]  S. Pérez-Hoyos,et al.  Differences between women and men in serial HIV prevalence and incidence trends , 2008, European Journal of Epidemiology.

[417]  M. Claeson.  Mapping and situation assessment of key populations at high risk of HIV in three cities of Afghanistan , 2008 .

[418]  J. Lau,et al.  Changes in the Prevalence of HIV-Related Behaviors and Perceptions Among 1832 Injecting Drug Users in Sichuan, China , 2008, Sexually transmitted diseases.

[419]  W. Lim,et al.  High prevalence of HCV in a cohort of injectors on methadone substitution treatment. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[420]  G. Ungvari,et al.  Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. , 2008, Drug and alcohol dependence.

[421]  D. Jolley,et al.  Attitudes of Australian Heroin Users to Peer Distribution of Naloxone for Heroin Overdose: Perspectives on Intranasal Administration , 2008, Journal of Urban Health.

[422]  S. Friedman,et al.  Greater Drug Injecting Risk for HIV, HBV, and HCV Infection in a City Where Syringe Exchange and Pharmacy Syringe Distribution are Illegal , 2008, Journal of Urban Health.

[423]  R. Pavarin.  [Mortality risk in intravenous drug users in Bologna and its determining factors. Results of a longitudinal study]. , 2008, Epidemiologia e prevenzione.

[424]  M. Brugal,et al.  Access to sterile syringes among young drug injectors in Madrid and Barcelona and its association with risk behaviour. , 2008, Gaceta sanitaria.

[425]  Y. Ruan,et al.  Willingness of Chinese injection drug users to participate in HIV vaccine trials. , 2008, Vaccine.

[426]  N. Jindal,et al.  Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India. , 2008, Japanese journal of infectious diseases.

[427]  I. Hoffman,et al.  Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission , 2008, AIDS.

[428]  J. Kimber,et al.  An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia , 2008 .

[429]  G. Dore,et al.  Experience of hepatitis C testing among injecting drug users in Sydney, Australia , 2008, AIDS care.

[430]  T. Krasnoselskikh,et al.  Sexually Transmitted Infections, Sexual Risk Behaviors and the Risk of Heterosexual Spread of HIV among and beyond IDUs in St. Petersburg, Russia , 2008, European Addiction Research.

[431]  D. Celentano,et al.  A Cross-Sectional Study on Prevalence of Non-Fatal Drug Overdose and Associated Risk Characteristics Among Out-of-Treatment Injecting Drug Users in North Vietnam , 2008, Substance use & misuse.

[432]  M. Amodeo,et al.  High-Frequency Users of Detoxification: Who Are They? , 2008, Substance use & misuse.

[433]  T. M. Piper,et al.  Evaluation of a Naloxone Distribution and Administration Program in New York City , 2008, Substance use & misuse.

[434]  Chen Meng-shi.  Investigation on the drug abuser in methadone maintenance treatment clinic in Changsha , 2008 .

[435]  M Mofizul Islam,et al.  Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. , 2008, Drug and alcohol review.

[436]  R. Allard,et al.  Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. , 2008, Social science & medicine.

[437]  R. Garfein,et al.  Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). , 2007, Drug and alcohol dependence.

[438]  G. Armstrong.  Injection drug users in the United States, 1979-2002: an aging population. , 2007, Archives of internal medicine.

[439]  English Version.  New Developments, Trends and in-depth information on selected issues , 2007 .

[440]  W. Miller,et al.  HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia , 2006, AIDS.

[441]  Eleanor Kastelova,et al.  The state of drug addiction and drug control in the Slovak Republic. 2006 national report (2005 data) to the EMCDDA by the Reitox National Focal Point. , 2006 .

[442]  M. Singer,et al.  Substance Abuse Treatment, Prevention, and Policy , 2006 .

[443]  Odd Hordvin.  2006 National report (2005 data) to the EMCDDA by the Reitox National Focal Point: Norway: new developments, trends and in-depth information on selected issues. , 2004 .

[444]  M. Krausz,et al.  HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS , 2002 .

[445]  L. Degenhardt,et al.  Estimating the prevalence of problematic drug use: a review of methods and their application , 2002 .

[446]  Raimondo Bruno,et al.  Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS) , 2006 .

[447]  S. Darke,et al.  A comparison of the harms associated with the injection of heroin and amphetamines. , 2000, Drug and alcohol dependence.

[448]  D. Desmond,et al.  An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. , 1999, The American journal of drug and alcohol abuse.

[449]  A. Ball,et al.  HIV prevention among injecting drug users: responses in developing and transitional countries. , 1998, Public health reports.